<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:media="http://search.yahoo.com/mrss/"><channel><title>Zibb.com: GlaxoSmithKline (Industry News &amp; Blogs)</title><link>http://www.zibb.com/all/theme/cq/GlaxoSmithKline</link><atom:link rel="self" type="application/rss+xml" href="http://www.zibb.com/all/theme/cq/GlaxoSmithKline" /><description>
					Zibb. The Global business search engine.
				</description><language>
					en-US
				</language><webMaster>search@zibb.com (RB Search)</webMaster><copyright>Copyright (c) 2007 Reed Business Information. All rights reserved.</copyright><pubDate>Thu, 26 Nov 2009 13:43:15 GMT</pubDate><lastBuildDate>Thu, 26 Nov 2009 13:43:15 GMT</lastBuildDate><ttl>60</ttl><image><title>Zibb.com: GlaxoSmithKline (Industry News &amp; Blogs)
          </title><width>88</width><height>31</height><link>http://www.zibb.com/all/theme/cq/GlaxoSmithKline</link><url>
						http://www.zibb.com/images/en/g_zibb_logo_beta.gif
					</url></image><item><title>Gilead Sciences and GlaxoSmithKline sign agreement to commerciali...
      </title><link>http://www.zibb.com/article/5695118/Gilead+Sciences+and+GlaxoSmithKline+sign+agreement+to+commercialize+Viread+R</link><description>Gilead Sciences, Inc. and GlaxoSmithKline plc (GSK) have signed a licensing agreement to commercialize Viread(R) (tenofovir disoproxil fumarate) for the treatment of chronic hepatitis B (HBV) infection in adults in five countries in Asia. Gilead is a US-based biopharmaceutical company, while GSK is</description><guid>http://www.zibb.com/article/5695118/Gilead+Sciences+and+GlaxoSmithKline+sign+agreement+to+commercialize+Viread+R</guid><category domain="http://www.zibb.com">GlaxoSmithKline</category><pubDate>Thu, 26 Nov 2009 13:43:15 GMT</pubDate><source url="http://www.zibb.com" /></item><item><title>Batch of swine flu vaccines studied in Canada (AP)</title><link>http://finance.yahoo.com/news/Batch-of-swine-flu-vaccines-apf-4027929862.html?x=0&amp;.v=2</link><description>LONDON (AP) -- Canadian doctors have been advised not to use a batch of 170,000 doses of swine flu vaccine while authorities investigate reports of allergic</description><guid>http://finance.yahoo.com/news/Batch-of-swine-flu-vaccines-apf-4027929862.html?x=0&amp;.v=2</guid><category domain="http://www.zibb.com">GlaxoSmithKline</category><pubDate>Tue, 24 Nov 2009 17:22:55 GMT</pubDate><source url="http://finance.yahoo.com" /></item><item><title>GlaxoSmithKline initiated with "market perform"</title><link>http://www.newratings.com/en/main/company_headline.m?id=1994376</link><description>NEW YORK, November 24 (newratings.com) - Analysts at Leerink Swann &amp; Co initiate coverage of GlaxoSmithKline (ticker: GSK) with a "market perform" rating. [more]</description><guid>http://www.newratings.com/en/main/company_headline.m?id=1994376</guid><category domain="http://www.zibb.com">GlaxoSmithKline</category><pubDate>Tue, 24 Nov 2009 16:44:16 GMT</pubDate><source url="http://www.newratings.com" /></item><item><title>Flu vaccine put on hold in Canada</title><link>http://news.bbc.co.uk/2/hi/americas/8376534.stm</link><description>GlaxoSmithKline tells doctors in Canada to stop using a batch of its swine flu, amid reports of severe side effects.</description><guid>http://news.bbc.co.uk/2/hi/americas/8376534.stm</guid><category domain="http://www.zibb.com">GlaxoSmithKline</category><pubDate>Tue, 24 Nov 2009 14:11:50 GMT</pubDate><source url="http://news.bbc.co.uk" /></item><item><title>GlaxoSmithKline pulls swine flu vaccines in Canada | R&amp;D Mag</title><link>http://rdmag.com/News/FeedsAP/2009/11/life-sciences-glaxosmithkline-pulls-swine-flu-vaccines-in-canada/</link><description>GlaxoSmithKline pulls batch of swine flu vaccines in Canada over severe allergy fears</description><guid>http://rdmag.com/News/FeedsAP/2009/11/life-sciences-glaxosmithkline-pulls-swine-flu-vaccines-in-canada/</guid><category domain="http://www.zibb.com">GlaxoSmithKline</category><pubDate>Tue, 24 Nov 2009 13:26:00 GMT</pubDate><source url="http://rdmag.com" /></item><item><title>GlaxoSmithKline pulls swine flu vaccines in Canada</title><link>http://www.sfgate.com/cgi-bin/article.cgi?f=/n/a/2009/11/24/international/i044024S26.DTL&amp;feed=rss.business</link><description>The pharmaceutical company GlaxoSmithKline says it has advised medical staff in Canada to not use one batch of swine flu vaccine for fear it may trigger life-threatening allergies. GlaxoSmithKline spokeswoman Gwenan White said Tuesday the company issued the...</description><guid>http://www.sfgate.com/cgi-bin/article.cgi?f=/n/a/2009/11/24/international/i044024S26.DTL&amp;feed=rss.business</guid><category domain="http://www.zibb.com">GlaxoSmithKline</category><pubDate>Tue, 24 Nov 2009 12:40:32 GMT</pubDate><source url="http://www.sfgate.com" /></item><item><title>Pawtucket Times - News from the Associated Press</title><link>http://hosted.ap.org/dynamic/stories/S/SWINE_FLU_VACCINE_RECALL?SITE=RIPAW&amp;SECTION=HOME&amp;TEMPLATE=DEFAULT</link><description>LONDON (AP) -- Canadian doctors have been advised not to use a batch of 170,000 swine flu vaccines after six reports of serious allergic reactions among recipients, but there are no similar reports from other countries, pharmaceuticals company GlaxoSmithKline PLC said Tuesday.</description><guid>http://hosted.ap.org/dynamic/stories/S/SWINE_FLU_VACCINE_RECALL?SITE=RIPAW&amp;SECTION=HOME&amp;TEMPLATE=DEFAULT</guid><category domain="http://www.zibb.com">GlaxoSmithKline</category><pubDate>Tue, 24 Nov 2009 05:06:24 GMT</pubDate><source url="http://hosted.ap.org" /></item><item><title>GlaxoSmithKline Recalls H1N1 Vaccine in Canada Over 'Life-Threate...
      </title><link>http://www.foxnews.com/story/0,2933,576526,00.html</link><description>GlaxoSmithKline Recalls H1N1 Vaccine in Canada Over 'Life-Threatening' Allergy Risk, The pharmaceutical company GlaxoSmithKline says it has advised medical staff in Canada to not use one batch of swine flu vaccine for fear it may trigger life-threatening allergies.</description><guid>http://www.foxnews.com/story/0,2933,576526,00.html</guid><category domain="http://www.zibb.com">GlaxoSmithKline</category><pubDate>Tue, 24 Nov 2009 04:57:39 GMT</pubDate><source url="http://www.foxnews.com" /></item><item><title>GlaxoSmithKline pulls application for new drug use</title><link>http://www.newsvine.com/_news/2009/11/23/3534947-glaxosmithkline-pulls-application-for-new-drug-use</link><description>British drugmaker GlaxoSmithKline PLC says it's withdrawing its application for U.S. approval of a drug to prevent prostate cancer.</description><guid>http://www.newsvine.com/_news/2009/11/23/3534947-glaxosmithkline-pulls-application-for-new-drug-use</guid><category domain="http://www.zibb.com">GlaxoSmithKline</category><pubDate>Mon, 23 Nov 2009 18:21:22 GMT</pubDate><source url="http://www.newsvine.com" /></item><item><title>GlaxoSmithKline Halts H1N1 Vaccinations In Canada</title><link>http://www.manufacturing.net/News-GlaxoSmithKline-Halts-H1N1-Vaccinations-In-Canada-112309.aspx</link><description>British drug maker is suspending 170,000 doses of its new H1N1 influenza vaccine in Canada given a higher-than-usual rate of reported side effects, Canadian media reported.</description><guid>http://www.manufacturing.net/News-GlaxoSmithKline-Halts-H1N1-Vaccinations-In-Canada-112309.aspx</guid><category domain="http://www.zibb.com">GlaxoSmithKline</category><pubDate>Mon, 23 Nov 2009 13:55:00 GMT</pubDate><source url="http://www.manufacturing.net" /></item><item><title>GlaxoSmithKline and Gilead Sciences, Inc. Announce Agreement to C...
      </title><link>http://www.biospace.com/news_story.aspx?StoryID=163784&amp;full=1</link><description>FOSTER CITY, Calif. &amp; LONDON--(BUSINESS WIRE)--Gilead Sciences, Inc. and GlaxoSmithKline today announced a licensing agreement to commercialize Viread® (tenofovir disoproxil fumarate) for the treatment of chronic hepatitis B (HBV) infection in adults in five countries in Asia.</description><guid>http://www.biospace.com/news_story.aspx?StoryID=163784&amp;full=1</guid><category domain="http://www.zibb.com">GlaxoSmithKline</category><pubDate>Mon, 23 Nov 2009 12:00:00 GMT</pubDate><source url="http://www.biospace.com" /></item><item><title>Drugmakers' Differences: Analyst's Toolkit (at TheStreet.com)</title><link>http://www.thestreet.com/_yahoo/story/10628002/1/drugmakers-differences-analysts-toolkit.html?cm_ven=YAHOO&amp;cm_cat=FREE&amp;cm_ite=NA</link><description>Pharmaceutical companies require their own metrics of evaluation. Sanofi, which looks strong in some ways, comes across as risky in others.. Check out TheStreet for the latest stock market news and financial investment headlines.</description><guid>http://www.thestreet.com/_yahoo/story/10628002/1/drugmakers-differences-analysts-toolkit.html?cm_ven=YAHOO&amp;cm_cat=FREE&amp;cm_ite=NA</guid><category domain="http://www.zibb.com">GlaxoSmithKline</category><pubDate>Wed, 18 Nov 2009 10:00:00 GMT</pubDate><source url="http://www.thestreet.com" /></item><item><title>GlaxoSmithKline, Nabi to develop smoking vaccine</title><link>http://www.usatoday.com/money/industries/health/2009-11-16-smoking-vaccine_N.htm?csp=34&amp;utm_source=feedburner&amp;utm_medium=feed&amp;utm_campaign=Feed%3A+UsatodaycomMoney-TopStories+%28Money+-+Top+Stories%29</link><description>GlaxoSmithKline PLC and Nabi Biopharmaceuticals said Monday they will work together to develop vaccines to help smokers give up the habit, in a deal that could be worth more than $500 million.</description><guid>http://www.usatoday.com/money/industries/health/2009-11-16-smoking-vaccine_N.htm?csp=34&amp;utm_source=feedburner&amp;utm_medium=feed&amp;utm_campaign=Feed%3A+UsatodaycomMoney-TopStories+%28Money+-+Top+Stories%29</guid><category domain="http://www.zibb.com">GlaxoSmithKline</category><pubDate>Mon, 16 Nov 2009 15:13:57 GMT</pubDate><source url="http://www.usatoday.com" /></item><item><title>FDA approves GlaxoSmithKlineâs H1N1 swine flu vaccine (at bizjour...
      </title><link>http://triangle.bizjournals.com/triangle/stories/2009/11/09/daily39.html?ana=yfcpc</link><description>The U.S. Food and Drug Administration has granted approval to GlaxoSmithKline’s H1N1 swine flu vaccine, the British pharmaceutical giant announced Tuesday. The U.S. government has ordered 7.</description><guid>http://triangle.bizjournals.com/triangle/stories/2009/11/09/daily39.html?ana=yfcpc</guid><category domain="http://www.zibb.com">GlaxoSmithKline</category><pubDate>Wed, 11 Nov 2009 16:05:21 GMT</pubDate><source url="http://triangle.bizjournals.com" /></item><item><title>GSK signs agreement with the WHO to donate 50 million doses of pa...
      </title><link>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=10360</link><description>GlaxoSmithKline (GSK) today announced that it has signed an agreement with the World Health Organization (WHO) to donate 50 million doses of its adjuvanted pandemic H1N1 influenza vaccine to WHO for distribution to developing countries most in need.</description><guid>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=10360</guid><category domain="http://www.zibb.com">GlaxoSmithKline</category><pubDate>Tue, 10 Nov 2009 01:00:00 GMT</pubDate><source url="http://www.pharmiweb.com" /></item><item><title>Global healthcare firms take notice as UAE expenditure on diabete...
      </title><link>http://www.ameinfo.com/215085.html</link><description>With an estimated $100m to $200m being spent by the UAE annually on the treatment of diabetes, it is crucial for key stakeholders in the healthcare industry to collaborate in ensuring the highest...</description><guid>http://www.ameinfo.com/215085.html</guid><category domain="http://www.zibb.com">GlaxoSmithKline</category><pubDate>Sat, 07 Nov 2009 09:26:30 GMT</pubDate><source url="http://www.ameinfo.com" /></item><item><title>Share tips: buy GlaxoSmithKline</title><link>http://www.telegraph.co.uk/finance/personalfinance/investing/shares-and-stock-tips/6486928/Share-tips-buy-GlaxoSmithKline.html</link><description>More share tips compiled by Hargreaves Lansdown. Also covered: Speedy Hire and McBride.</description><guid>http://www.telegraph.co.uk/finance/personalfinance/investing/shares-and-stock-tips/6486928/Share-tips-buy-GlaxoSmithKline.html</guid><category domain="http://www.zibb.com">GlaxoSmithKline</category><pubDate>Mon, 02 Nov 2009 15:13:47 GMT</pubDate><source url="http://www.telegraph.co.uk" /></item><item><title>glaxosmithkline dips despite positive drug news - guardian.co.uk</title><link>http://www.guardian.co.uk/business/marketforceslive/2009/nov/02/glaxosmithkline</link><description>Weakness in the pharmaceutical sector has left GlaxoSmithKline lower despite a positive announcement on new drug trials</description><guid>http://www.guardian.co.uk/business/marketforceslive/2009/nov/02/glaxosmithkline</guid><category domain="http://www.zibb.com">GlaxoSmithKline</category><pubDate>Mon, 02 Nov 2009 12:10:47 GMT</pubDate><source url="http://www.guardian.co.uk" /></item><item><title>GlaxoSmithKline Posts 11% Rise in Q3 Net Profit (at SmartMoney.co...
      </title><link>http://www.smartmoney.com/breaking-news/on/?story=ON-20091030-000393-0409&amp;afl=yahoo</link><description>BANGALORE -(Dow Jones)- GlaxoSmithKline Pharmaceuticals Ltd. (500660.BY), the Indian unit of GlaxoSmithKline PLC (GSK.LN), Friday said its third quarter net profit rose 6.8% from a year earlier.</description><guid>http://www.smartmoney.com/breaking-news/on/?story=ON-20091030-000393-0409&amp;afl=yahoo</guid><category domain="http://www.zibb.com">GlaxoSmithKline</category><pubDate>Fri, 30 Oct 2009 07:09:00 GMT</pubDate><source url="http://www.smartmoney.com" /></item><item><title>Drug Development: Investigators at GlaxoSmithKline zero in on dru...
      </title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3536214&amp;HITNO=10&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=biotechnology%20pharmaceutical&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R%3adate&amp;R=3536214&amp;THISHREF=http%3a//c.moreover.com/click/here.pl%3fz2294174140%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><description>Biotechnology and Pharmaceutical Industry Search Find Companies, News, Events, Jobs, Directory</description><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3536214&amp;HITNO=10&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=biotechnology%20pharmaceutical&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R%3adate&amp;R=3536214&amp;THISHREF=http%3a//c.moreover.com/click/here.pl%3fz2294174140%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><category domain="http://www.zibb.com">GlaxoSmithKline</category><pubDate>Thu, 29 Oct 2009 09:52:49 GMT</pubDate><source url="http://www.bioportfolio.co.uk" /></item><item><title>GlaxoSmithKline third quarter profit up 11 percent</title><link>http://www.examiner.com/a-2291388~GlaxoSmithKline_third_quarter_profit_up_11_percent.html?cid=rss-Business</link><description>GlaxoSmithKline PLC, the world's second largest drug maker by revenue, posted Wednesday an 11 percent rise in third quarter earnings on the back of strong sales of the flu drug Relenza and forecast an even bigger boost from its swine flu vaccines in the final quarter of the year.</description><guid>http://www.examiner.com/a-2291388~GlaxoSmithKline_third_quarter_profit_up_11_percent.html?cid=rss-Business</guid><category domain="http://www.zibb.com">GlaxoSmithKline</category><pubDate>Wed, 28 Oct 2009 17:14:23 GMT</pubDate><source url="http://www.examiner.com" /></item><item><title>GlaxoSmithKline quarterly profit jumps, sales up (at MarketWatch)</title><link>http://www.marketwatch.com/story/glaxosmithkline-quarterly-profit-jumps-sales-up-2009-10-28?siteid=yhoof2</link><description>LONDON+(MarketWatch)+--+Europe's+biggest+drugmaker+GlaxoSmithKline+++said+Wednesday+that+its+third-quarter+attributable+profit+rose+to+1.34+billion+pounds+(%242.19+billion)%2c+from+1.0+billion+pounds+last+year.+Sales+increased+to+6.76+billion+pounds%2c+from+5.88+billion+pounds+a+year+ago.+Analysts+h</description><guid>http://www.marketwatch.com/story/glaxosmithkline-quarterly-profit-jumps-sales-up-2009-10-28?siteid=yhoof2</guid><category domain="http://www.zibb.com">GlaxoSmithKline</category><pubDate>Wed, 28 Oct 2009 12:13:49 GMT</pubDate><source url="http://www.marketwatch.com" /></item><item><title>Catalent Awarded for H1N1 Project with GSK</title><link>http://www.pharmamanufacturing.com/industrynews/2009/180.html?CMP=ILC-rss</link><description>Catalent Pharma Solutions, a leading provider of outsourced clinical and commercial packaging services to the global pharmaceutical and biotechnology industry, has won for the second year in a row The Best Contract Manufacturing Project award at this year s European Outsourcing Awards ceremony.</description><guid>http://www.pharmamanufacturing.com/industrynews/2009/180.html?CMP=ILC-rss</guid><category domain="http://www.zibb.com">GlaxoSmithKline</category><pubDate>Tue, 20 Oct 2009 07:00:58 GMT</pubDate><source url="http://www.pharmamanufacturing.com" /></item><item><title>Paxil Verdict In: Big Loss for GlaxoSmithKline</title><link>http://www.pointoflaw.com/archives/2009/10/paxil-verdict-i.php</link><description>As I noted here in September, a trial to watch is the one in Philadelphia where Michelle David, a former cheerleader for the Philadelphia 76ers, sued personally and on behalf of her 3-year-old son Lyam Kilker, claiming that the latter's...</description><guid>http://www.pointoflaw.com/archives/2009/10/paxil-verdict-i.php</guid><category domain="http://www.zibb.com">GlaxoSmithKline</category><pubDate>Wed, 14 Oct 2009 11:04:12 GMT</pubDate><source url="http://www.pointoflaw.com" /></item><item><title>GlaxoSmithKline overhauls Poligrip denture brand - Brand Republic...
      </title><link>http://www.brandrepublic.com/News/944153/GSK-strengthens-its-Poligrip-denture-brand/</link><description>GlaxoSmithKline overhauls Poligrip denture brand - Brand Republic News. Read GlaxoSmithKline overhauls Poligrip denture brand and other marketing news at Brand Republic. Brand Republic - first for Advertising, Marketing, Media and PR</description><guid>http://www.brandrepublic.com/News/944153/GSK-strengthens-its-Poligrip-denture-brand/</guid><category domain="http://www.zibb.com">GlaxoSmithKline</category><pubDate>Wed, 07 Oct 2009 17:00:00 GMT</pubDate><source url="http://www.brandrepublic.com" /></item></channel></rss>